BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15509792)

  • 1. The Wt1+/R394W mouse displays glomerulosclerosis and early-onset renal failure characteristic of human Denys-Drash syndrome.
    Gao F; Maiti S; Sun G; Ordonez NG; Udtha M; Deng JM; Behringer RR; Huff V
    Mol Cell Biol; 2004 Nov; 24(22):9899-910. PubMed ID: 15509792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
    Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
    Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and pathological features of Denys-Drash syndrome: report of 3 cases].
    Wang HY; Sun LZ; Yue ZH; Yang J; Jiang XY; Mo Y
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):855-8. PubMed ID: 23302619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Denys-Drash syndrome with neonatal renal failure in monozygotic twins due to c.1097G>A mutation in the WT1 gene.
    Furtado LV; Pysher T; Opitz J; Lamb R; Comstock J; Batish S; Mauch T; Nelson R; Zhou H
    Fetal Pediatr Pathol; 2011; 30(4):266-72. PubMed ID: 21434831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.
    Heathcott RW; Morison IM; Gubler MC; Corbett R; Reeve AE
    Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel WT1 gene mutation in a three-generation family with progressive isolated focal segmental glomerulosclerosis.
    Benetti E; Caridi G; Malaventura C; Dagnino M; Leonardi E; Artifoni L; Ghiggeri GM; Tosatto SC; Murer L
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):698-702. PubMed ID: 20150449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclerosis.
    Löwik M; Levtchenko E; Westra D; Groenen P; Steenbergen E; Weening J; Lilien M; Monnens L; van den Heuvel L
    Nephrol Dial Transplant; 2008 Oct; 23(10):3146-51. PubMed ID: 18443213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Denys-Drash syndrome.
    Kucinskas L; Rudaitis S; Pundziene B; Just W
    Medicina (Kaunas); 2005; 41(2):132-4. PubMed ID: 15758579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal Segmental Membranoproliferative Glomerulonephritis: A Histological Variant of Denys-Drash Syndrome.
    Karmila AB; Yap YC; Appadurai M; Oh L; Fazarina M; Abd Ghani F; Ariffin H
    Fetal Pediatr Pathol; 2021 Apr; 40(2):113-120. PubMed ID: 31707902
    [No Abstract]   [Full Text] [Related]  

  • 11. WT1 intron 9 splice acceptor site mutation in a 46,XY male with focal segmental glomerulosclerosis.
    Kanemoto K; Ishikura K; Ariyasu D; Hamasaki Y; Hataya H; Hasegawa Y; Ikeda M
    Pediatr Nephrol; 2007 Mar; 22(3):454-8. PubMed ID: 17061122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on kidney disease, fertility and development in mice inheriting a protein-truncating Denys-Drash syndrome allele (Wt1tmT396).
    Patek CE; Brownstein DG; Fleming S; Wroe C; Rose L; Webb A; Berry RL; Devenney PS; Walker M; Maddocks OD; Lawrence NJ; Harrison DJ; Wood KM; Miles CG; Hooper ML
    Transgenic Res; 2008 Jun; 17(3):459-75. PubMed ID: 18040647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome.
    da Silva TE; Nishi MY; Costa EM; Martin RM; Carvalho FM; Mendonca BB; Domenice S
    Pediatr Nephrol; 2011 Aug; 26(8):1311-5. PubMed ID: 21559934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic bilateral nephrectomy and preemptive kidney transplantation for Denys-Drash syndrome prior to development of kidney failure.
    Hosokawa C; Hotta K; Okamoto T; Cho Y; Hirose T; Iwahara N; Manabe A; Shinohara N
    Pediatr Nephrol; 2024 Mar; 39(3):905-909. PubMed ID: 37572117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective mutational analysis of NPHS1, NPHS2, WT1 and LAMB2 in children with steroid-resistant focal segmental glomerulosclerosis - a single-centre experience.
    Bińczak-Kuleta A; Rubik J; Litwin M; Ryder M; Lewandowska K; Taryma-Leśniak O; Clark JS; Grenda R; Ciechanowicz A
    Bosn J Basic Med Sci; 2014 May; 14(2):89-93. PubMed ID: 24856380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms' Tumor 1 Target Genes in Podocyte Differentiation and Maintenance.
    Dong L; Pietsch S; Tan Z; Perner B; Sierig R; Kruspe D; Groth M; Witzgall R; Gröne HJ; Platzer M; Englert C
    J Am Soc Nephrol; 2015 Sep; 26(9):2118-28. PubMed ID: 25556170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development.
    Natoli TA; Liu J; Eremina V; Hodgens K; Li C; Hamano Y; Mundel P; Kalluri R; Miner JH; Quaggin SE; Kreidberg JA
    J Am Soc Nephrol; 2002 Aug; 13(8):2058-67. PubMed ID: 12138137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and pathological features and mutational types of WT1 mutation-associated nephropathy].
    Sun LZ; Wang HY; Li M; Lin HR; Wu JL; Tang W; Li YJ; Yue ZH; Liu T; Chen HM; Hu MY
    Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):769-774. PubMed ID: 30293282
    [No Abstract]   [Full Text] [Related]  

  • 19. A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome.
    Little S; Hanks S; King-Underwood L; Picton S; Cullinane C; Rapley E; Rahman N; Pritchard-Jones K
    Pediatr Nephrol; 2005 Jan; 20(1):81-5. PubMed ID: 15503171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel WT1 gene mutation p.H377N associated to Denys-Drash syndrome.
    Guaragna MS; Soardi FC; Assumpção JG; Zambaldi Lde J; Cardinalli IA; Yunes JA; de Mello MP; Brandalise SR; Aguiar Sdos S
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):486-8. PubMed ID: 20562648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.